# XmAb5871 Bioavailability Study

> **NCT02867098** · PHASE1 · COMPLETED · sponsor: **Xencor, Inc.** · enrollment: 50 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** XmAb5871

## Key facts

- **NCT ID:** NCT02867098
- **Lead sponsor:** Xencor, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2016-10-21
- **Final completion:** 2016-10-21
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2017-12-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02867098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02867098, "XmAb5871 Bioavailability Study". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT02867098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*